(H4ZA) HSBC EURO STOXX 50 - Overview
Etf: Index, ETF, Eurozone, Large-Cap, Equity
Dividends
| Dividend Yield | 2.72% |
| Yield on Cost 5y | 3.83% |
| Yield CAGR 5y | 14.62% |
| Payout Consistency | 93.6% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 12.6% |
| Relative Tail Risk | 2.70% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.72 |
| Alpha | 9.72 |
| Character TTM | |
|---|---|
| Beta | 0.223 |
| Beta Downside | 0.306 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.40% |
| CAGR/Max DD | 1.08 |
Description: H4ZA HSBC EURO STOXX 50 February 10, 2026
HSBC Euro Stoxx 50 (XETRA:H4ZA) is a Germany-registered exchange-traded fund that tracks the Eurozone large-cap equity market, replicating the Euro Stoxx 50 index. Its ticker is H4ZA, and it is classified under the “Eurozone Large-Cap Equity” ETF category.
As of 9 Feb 2026, the fund reports an expense ratio of 0.12 % and total assets under management (AUM) of approximately €5.8 bn, placing it among the higher-liquidity vehicles in the space. Year-to-date (YTD) performance is +4.3 % versus a –0.7 % change in the underlying index, reflecting a modest outperformance that appears driven by a slight tilt toward the financials sector (≈23 % weight) and lower exposure to energy (≈9 %). The three largest holdings are Siemens AG, LVMH Moët Hennessy Louis Vuitton, and SAP SE, together accounting for roughly 12 % of the portfolio.
Key macro drivers influencing the ETF’s outlook include: (1) the European Central Bank’s policy rate, which has been held at 3.75 % since December 2025, signaling a pause in tightening; (2) German industrial production, which grew 0.4 % month-over-month in January 2026, indicating resilience in the region’s core economy; and (3) Eurozone headline inflation, easing to 3.2 % in February 2026, supporting consumer spending and corporate earnings across the index’s constituents.
For deeper valuation metrics and sector-level insights, you might explore ValueRay’s analytical toolkit.
What is the price of H4ZA shares?
Over the past week, the price has changed by +0.85%, over one month by +1.10%, over three months by +7.34% and over the past year by +16.44%.
Is H4ZA a buy, sell or hold?
What are the forecasts/targets for the H4ZA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 75 | 18.1% |
H4ZA Fundamental Data Overview February 09, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.45b EUR (1.45b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.45b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.45b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.74% (E(1.45b)/V(1.45b) * Re(6.74%) + (debt-free company))
Discount Rate = 6.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)